Low prealbumin does not prove malnutrition: inflammation, liver function, kidney function, and fluid balance can change the result independently of food intake. A useful interpretation connects the number with weight changes, muscle loss, actual intake, and the illness behind the test.
Mambo muhimu ya kukumbuka
- Low prealbumin means a circulating protein concentration is below your laboratory's interval; a result of 12 mg/dL does not establish malnutrition.
- Prealbumin normal range is commonly approximately 20–40 mg/dL in adults, equivalent to 0.20–0.40 g/L, but laboratories use different intervals.
- Kuvimba can reduce prealbumin production despite adequate eating; its approximately 2–3-day half-life makes illness-related changes appear quickly.
- CRP context helps explain low prealbumin, but there is no validated CRP correction formula that converts the result into nutritional status.
- Malnutrition diagnosis under GLIM requires at least 1 phenotypic criterion and 1 etiologic criterion after nutritional risk screening—not a low protein result alone.
- Weight loss greater than 5% within 6 months is a GLIM phenotypic criterion, even when BMI remains above the usual healthy-weight interval.
- Nutrition support should address documented needs and eating barriers; general NICE estimates of 25–35 kcal/kg/day are not suitable starting targets for everyone.
- Refeeding risk needs clinical assessment after prolonged minimal intake; more than 10 days with little or no nutrition is one NICE high-risk criterion.
Does low prealbumin mean you are malnourished?
Low prealbumin can accompany malnutrition, but it cannot diagnose it. A concentration of 12 mg/dL may reflect inflammation, impaired liver production, inadequate intake, or several factors together; nutritional status requires assessment of weight, muscle, intake, and the underlying illness.
A laboratory flag describes the concentration of one protein, not the amount of protein stored in your muscles. The 2021 ASPEN position paper states that albumin and prealbumin primarily characterize inflammation rather than nutritional status and should not be used as proxies for body protein or muscle mass (Evans et al., 2021). Low values can still identify people who need closer clinical attention.
Consider a hypothetical adult who eats their usual meals but develops pneumonia and has prealbumin of 11 mg/dL. Another adult with the same result may have eaten very little for 3 weeks because swallowing is difficult; the identical number does not tell clinicians which explanation applies. Both deserve assessment, but the treatment priorities are different.
Kantesti is an AI blood test analyzer that helps explain why a prealbumin result of 12 mg/dL needs clinical context rather than an automatic malnutrition label. Our shirika na kusudi letu include making laboratory information understandable—not replacing a clinician's examination or a dietitian's assessment. The useful question is what explains the result and what evidence independently establishes a nutrition problem.
What is the prealbumin normal range?
A commonly used adult prealbumin normal range is approximately 20–40 mg/dL, equivalent to 0.20–0.40 g/L. Your report's own interval takes priority because age, assay method, and the laboratory's reference population affect the limits.
Different reference intervals do not necessarily mean that one laboratory is wrong. Some reports use intervals around 15–36 mg/dL, so a hypothetical value of 18 mg/dL could be flagged by one laboratory and unflagged by another; neither classification independently establishes nutritional adequacy. Reference intervals describe a comparison population, whereas diagnostic criteria must identify a clinically meaningful condition.
Unit conversion can prevent a much larger misunderstanding than a borderline flag. Prealbumin of 200 mg/L equals 20 mg/dL and 0.20 g/L; a report showing 0.18 g/L therefore means 18 mg/dL, not an extraordinarily tiny concentration. Before comparing two reports, match the units, laboratory interval, and sampling circumstances rather than comparing the printed numbers alone.
A concentration below 10 mg/dL is substantially below many adult reference intervals, but there is no universal prealbumin-only emergency threshold or validated severity scale for malnutrition. The mwongozo wa albin na protini za seramu explains why circulating proteins are not interchangeable with nutritional assessment. Pediatric results require age-specific interpretation; the adult table below should not be applied to children.
| Kiwango | Wigo | Maana yake |
|---|---|---|
| Kipimo cha kawaida cha watu wazima | 20–40 mg/dL | Within one commonly used interval; does not exclude malnutrition. |
| Below this example interval | 10–<20 mg/dL | Tathmini uvimbe, ulaji, utendaji wa ini, utendaji wa figo na uwiano wa maji mwilini. |
| Chini sana ya kiwango hiki | <10 mg/dL | Inahitaji ufafanuzi wa kitabibu; si kipimo cha pekee cha kiwango cha utapiamlo wala kizingiti cha dharura. |
| Juu ya kiwango hiki cha mfano | >40 mg/dL | Huenda ikatokea kutokana na kupungua kwa uvunjaji wa protini kwenye figo au athari za dawa; haithibitishi lishe bora kabisa. |
What does the prealbumin test actually measure?
Kipimo cha prealbumin hupima transthyretin, protini ya usafirishaji inayozalishwa hasa na ini kwa ajili ya mzunguko wa damu. Nusu ya maisha yake ya takriban siku 2–3 huruhusu mabadiliko ya haraka kiasi, lakini mwitikio wa haraka hauifanyi kuwa kipimo mahususi cha ulaji wa chakula.
Prealbumin si aina isiyokomaa ya albumin na haibadiliki kuwa albumin. Jina hilo limetokana na kusogea kwake mbele ya albumin wakati wa elektroferezia; albumin ina nusu ya maisha ya mzunguko wa damu iliyo ndefu zaidi, takriban siku 20, ikilinganishwa na takriban siku 2–3 za prealbumin. Viwango hivi tofauti vya ubadilishanaji vinaeleza kwa nini matokeo hayo mawili yanaweza kubadilika kwa kasi tofauti wakati wa ugonjwa.
Kwa kawaida, transthyretin huunda tetrameri yenye vitengo 4 vya protini na husafirisha kiasi fulani cha thyroxine inayozunguka mwilini, au T4. Pia huingiliana na protini inayofunga retinol, ambayo husafirisha vitamini A; hata hivyo, kiwango cha chini cha prealbumin hakitambui chenyewe ugonjwa wa tezi wala upungufu wa vitamini A. Kiwango cha protini ya usafirishaji, utendaji wa homoni na akiba ya virutubishi kwenye tishu hujibu maswali tofauti ya kibayolojia.
Kiwango cha chini pia ni tofauti na kugundua lahaja inayohusishwa na ugonjwa katika jeni la TTR. Matokeo ya kubuniwa ya prealbumin ya 14 mg/dL si matokeo ya uchunguzi wa vinasaba na hayatambui amiloidosisi ya kurithi ya ATTR; tathmini hiyo hufuata mkondo tofauti wa kitabibu na kijenetiki. Maelezo yetu kuhusu lahaja za TTR na amiloidosisi husaidia kutofautisha maana hizi zinazochanganywa kwa urahisi za jina lilelile la protini.
Why does inflammation lower prealbumin despite eating?
Prealbumin ni protini ya awamu ya papo hapo hasi: kiwango chake katika mzunguko wa damu mara nyingi hushuka wakati wa uvimbe, uzalishaji wa protini na ini unapobadilika. Kwa hivyo, thamani ya kubuniwa ya 10 mg/dL wakati wa ugonjwa mkali inaweza kutokea hata kama ulaji wa hivi karibuni wa kalori na protini umekuwa wa kutosha.
Ishara za uvimbe hubadilisha kile ambacho ini huzalisha badala ya kuashiria tu kwamba mgonjwa ameruka milo. Viashiria kama vile interleukin-6 huchochea mwitikio wa awamu ya papo hapo, huku viwango vya protini kama prealbumin vikishuka; nusu ya maisha yake ya siku 2–3 hufanya mabadiliko hayo kuwa ya haraka kiasi. Mwongozo wa tafsiri ya IL-6 unaeleza kwa nini muda na muktadha wa ugonjwa ni muhimu, ingawa upimaji wa IL-6 kwa kawaida hauhitajiki kutathmini lishe.
Uvimbe unaweza kushusha prealbumin bila kutegemea ulaji na pia kuongeza hatari ya utapiamlo kupitia kupoteza hamu ya kula na uvunjaji wa tishu. Hizi ni michakato 2 inayopishana, wala si maelezo yanayoshindana: mwanzoni mtu anaweza kula vya kutosha, lakini akapoteza misuli wakati wa ugonjwa wa muda mrefu kwa sababu mahitaji ya kimetaboliki ya mwili na uvunjaji wa tishu vimebadilika. Kwa hivyo, kusema kuwa matokeo hayo yanasababishwa na 'uvimbe tu' kunaweza kupotosha sawa na kusema kuwa yanathibitisha njaa.
Protini nyingine za awamu ya papo hapo hasi zinaweza kubadilika katika mwelekeo huohuo, hivyo mchanganyiko wa prealbumin ya chini na transferrin ya chini hautoi uthibitisho 2 huru wa utapiamlo. Mwitikio wao wa pamoja kwa uvimbe unaweza kuunda muundo unaoonekana kushawishi, ilhali unatokana na utaratibu uleule wa msingi. Mwongozo wetu kuhusu uvimbe na transferrini ya chini hueleza kwa nini madaktari huchunguza kisababishi kabla ya kutafsiri protini kadhaa za usafirishaji zilizo chini kama upungufu wa lishe.
How should prealbumin and CRP be read together?
CRP husaidia kutambua muktadha wa uvimbe, lakini haiwezi kubadilisha prealbumini kuwa alama ya lishe. Mchanganyiko wa kubuniwa wa prealbumini 12 mg/dL na CRP 90 mg/L huongeza sana wasiwasi kwamba mwitikio wa awamu kali unaathiri matokeo ya protini.
CRP ya kawaida hupunguza ushahidi wa mwitikio mkubwa wa kimfumo wa awamu kali wakati huo, lakini haithibitishi kwamba prealbumini ya chini inatokana na lishe. Maabara nyingi hutumia kiwango cha juu cha CRP cha takriban 5 mg/L, huku nyingine zikitumia 10 mg/L; muda wa kuchukua sampuli, ugonjwa ulio katika eneo fulani, na ugonjwa wa ini vinaweza kutatiza tafsiri. Hakuna kiwango cha chini cha CRP kinachokubalika kote ambacho chini yake prealbumini huwa kipimo kilichothibitishwa cha utapiamlo.
Alama za uvimbe zisizolingana zinapaswa kusababisha maswali kuhusu muda, dalili na matibabu badala ya kutafuta njia ya kihisabati ya kurekebisha matokeo. Mgonjwa wa kubuniwa mwenye prealbumini 13 mg/dL, CRP 4 mg/L na hesabu ya kawaida ya seli nyeupe za damu bado anahitaji historia ya ulaji wa chakula na uzito; madaktari wanaweza pia kuchunguza utendaji wa ini au dalili zinazoendelea. Majadiliano yetu kuhusu alama za maambukizi zinazokinzana yanaeleza kwa nini alama moja inayotia moyo haiwezi kutoa picha kamili ya hali ya kliniki.
Kantesti AI inaweza kuwasaidia wasomaji kutofautisha matokeo ya prealbumini ya 12 mg/dL na matokeo ya CRP ya 90 mg/L na kuelewa mchango wa kila kipimo. Uwiano wa prealbumini na CRP wala kugawa thamani moja kwa nyingine si mbadala unaokubalika wa tathmini ya lishe. Ikiwa CRP haijapimwa, kutokuwa na uhakika huko kunapaswa kubaki wazi—si kufichwa kwa utambuzi wa lishe ulio na uhakika usiofaa.
How do liver and kidney disease change prealbumin?
Ugonjwa wa ini unaweza kupunguza uzalishaji wa prealbumini, huku utendaji dhaifu wa figo unaweza kuongeza ukolezi wake kwa kupunguza uvunjaji wake. Kwa hiyo, thamani ya 15 mg/dL au 45 mg/dL haiwezi kutafsiriwa kuwa lishe duni au bora bila kujua hali ya utendaji wa viungo.
Kupungua kwa uwezo wa ini wa kutengeneza protini ni tofauti na ongezeko la pekee la kimeng'enya cha ini. Thamani ya kubuniwa ya ALT ya 80 IU/L haipimi kiasi cha prealbumini ambacho ini linaweza kuzalisha; madaktari huzingatia mwelekeo mpana zaidi, ikiwemo albumini, bilirubini, matokeo ya mgando wa damu, historia na uchunguzi. Mwongozo dalili za kimaabara za cirrhosis unaeleza kwa nini mabadiliko yanayoonekana kuwa madogo ya vimeng'enya yanaweza kutokea pamoja na hitilafu kubwa zaidi ya utendaji wa ini.
Ugonjwa wa figo unaweza kuathiri matokeo katika mielekeo zaidi ya mmoja kwa sababu kupungua kwa uvunjaji wa prealbumini kunaweza kuipandisha, ilhali uvimbe au ulaji duni unaotokea sambamba nayo huishusha. Mtu mzima wa kubuniwa mwenye eGFR 25 mL/min/1.73 m² na prealbumini 38 mg/dL bado anaweza kuwa na upungufu mkubwa wa uzito na misuli unaohusika kiafya. Mwongozo wetu kuhusu dalili za onyo za eGFR ya chini unaeleza matokeo ya figo yanayostahili kuangaliwa zaidi ya protini hii ya usafirishaji.
Upotevu wa protini kwenye mkojo unapaswa kupimwa moja kwa moja badala ya kuhitimishwa kutokana na prealbumini. Vipimo vya albumini au protini kwenye mkojo, albumini ya seramu na tathmini ya figo hujibu maswali ambayo ukolezi wa prealbumini wa 16 mg/dL hauwezi kuyatatua; hali za nefrotiki hazisababishi mwelekeo wa prealbumini unaoweza kutabiriwa kwa uhakika. Hatua ya vitendo ni kuleta matokeo ya figo na ya ini kwenye miadi hiyo hiyo, hasa kabla ya kubadilisha kwa kiasi kikubwa ulaji wa protini.
Can fluids, medicines, or assay problems alter results?
Usawaziko wa maji mwilini, baadhi ya dawa na mwingiliano wa kipimo maalumu kwa mbinu ya uchunguzi vinaweza kubadilisha matokeo ya kipimo cha prealbumini. Kupungua kwa kubuniwa kutoka 22 hadi 16 mg/dL baada ya kupewa kiasi kikubwa cha maji kunaweza kuakisi kwa kiasi fulani dilusheni badala ya mabadiliko ya ghafla katika akiba ya lishe.
Prealbumini ni kipimo cha ukolezi, kwa hiyo kiasi cha maji yanayozunguka mwilini huathiri namna matokeo yanavyoonyeshwa. Kuhifadhi maji kwa haraka kunaweza kupunguza ukolezi uliopimwa, huku upungufu wa maji mwilini ukiweza kuupandisha; ongezeko la uzito la kilo 3 katika siku kadhaa linaweza kuwa maji badala ya tishu mpya. Kwa hiyo, madaktari hutofautisha kuongezeka kwa uzito kunakotokana na nafuu na edema, na huepuka kutafsiri ukolezi wa protini unaopungua pekee baada ya ufufuaji wa maji mwilini.
Kortikosteroidi zinaweza kuongeza ukolezi wa prealbumini, ingawa matokeo ya jumla pia hutegemea ugonjwa unaotibiwa. Mabadiliko ya kubuniwa kutoka 18 hadi 25 mg/dL baada ya matibabu ya kortikosteroidi yanaweza kuakisi athari za dawa, kupungua kwa uvimbe, mabadiliko ya lishe au mchanganyiko wa mambo hayo yote 3. Andika jina la dawa, dozi na tarehe ya kuanza badala ya kudhani kwamba kila ongezeko linamaanisha mpango wa lishe umefanikiwa.
Matokeo ya pekee yasiyotarajiwa yanastahili kukaguliwa kwa vitengo, ubora wa sampuli na maelezo ya maabara kuhusu mwingiliano wa kipimo kabla ya kufanya mabadiliko makubwa ya lishe. Prealbumini ya kubuniwa ya 9 mg/dL pamoja na matokeo kadhaa yasiyotarajiwa ya vipimo inaweza kutoa sababu ya kushauriana na maabara; mwingiliano hutegemea mbinu, na si jambo linalohitaji kila mgonjwa kupimwa tena. Ufafanuzi wetu kuhusu uvimbe na zinki ya plasma also shows why several low circulating nutrients or proteins may share a non-dietary explanation.
What criteria actually diagnose adult malnutrition?
GLIM diagnoses adult malnutrition using at least 1 phenotypic criterion and 1 etiologic criterion after nutritional risk screening. Phenotypic criteria include weight loss, low BMI, or reduced muscle mass; etiologic criteria include reduced intake or assimilation, or inflammation and disease burden.
The international GLIM consensus uses unintentional weight loss greater than 5% within 6 months, or greater than 10% beyond 6 months, as a phenotypic criterion (Cederholm et al., 2019). A hypothetical change from 70 to 66 kg is approximately 5.7% loss, even if the person still appears well nourished. The timing and whether the loss was intended matter as much as the arithmetic.
GLIM's commonly used non-Asian low-BMI thresholds are below 20 kg/m² for adults younger than 70 and below 22 kg/m² for adults aged 70 or older, with population-specific adaptations. These are diagnostic-framework thresholds, not universal healthy-weight boundaries; reduced muscle mass can establish a phenotype even when BMI is higher. Neither BMI nor prealbumin alone captures how much functional tissue a person has lost.
Kantesti is an AI biomarker interpretation platform that explains why prealbumin of 14 mg/dL cannot replace GLIM's clinical criteria. Specific deficiencies can coexist with malnutrition, but a low folate result is a different diagnostic question from total calorie and protein adequacy; our guide to folate deficiency causes makes that distinction. A nutrition assessment should identify the syndrome and its cause, not collect abnormal laboratory flags as a substitute.
What should a proper nutrition assessment include?
A useful nutrition assessment documents weight trajectory, actual intake, eating barriers, muscle changes, and disease burden. Reviewing the previous 1–6 months often reveals more than a single prealbumin concentration, particularly when fluid retention or a higher BMI hides tissue loss.
A higher BMI does not exclude malnutrition after substantial unintentional weight loss. A hypothetical adult weighing 80 kg who falls to 74 kg has lost 7.5%; at 1.65 m tall, the current BMI remains approximately 27.2 kg/m² despite that meaningful change. Clinicians ask whether clothing fits differently, strength has declined, and swelling is masking further tissue loss rather than judging nutritional status from appearance.
Reduced intake should be investigated as a symptom with a cause, not treated as a failure of motivation. Difficulty swallowing, painful eating, nausea, dental problems, limited food access, and medication effects require different solutions; a 3-day food record can help describe the pattern but does not diagnose malabsorption. Persistent swallowing problems may need evaluation such as the pathway described in our achalasia diagnostic guide.
Digestive investigations should follow symptoms and risk factors instead of being ordered because prealbumin is below 20 mg/dL. Chronic diarrhea with weight loss may warrant targeted evaluation for intestinal disease, whereas visible food fragments alone do not establish nutrient malabsorption. Our guide to stool inflammation tests explains what those tests can contribute; muscle assessment and intake history still remain necessary even when gastrointestinal testing identifies a cause.
When is repeating prealbumin actually useful?
Repeating prealbumin is useful only when the result will answer a defined clinical question. Its 2–3-day half-life does not justify routine testing every few days, and an increase cannot independently prove that nutrition treatment has restored muscle or body protein.
Prealbumin can rise as inflammation resolves even when food intake has changed very little. In a hypothetical recovery, prealbumin increases from 10 to 18 mg/dL while CRP falls from 120 to 8 mg/L over 10 days; the pattern supports a changing acute-phase response but cannot quantify how much nutrition contributed. Improved concentration is not equivalent to restored strength, healed tissue, or replenished lean mass.
If a clinician chooses to repeat testing, an interval such as 1–2 weeks after a meaningful clinical change may be reasonable, but it is not a universal guideline schedule. Record the illness course, fluid status, medication changes, intake, and laboratory method at both time points. Our guide to meaningful laboratory trends explains why the circumstances surrounding each measurement determine whether comparison is informative.
Kantesti can help organize dated prealbumin measurements, but 2 results cannot reveal unrecorded food intake or establish muscle recovery. ASPEN's 2021 position paper advises against using visceral proteins as nutrition markers, so clinical outcomes and documented intake should lead monitoring rather than a target prealbumin value (Evans et al., 2021). Ask what management decision would change before arranging another measurement.
Should you increase protein to raise prealbumin?
Increase nutrition when an assessment identifies inadequate intake or increased needs—not simply to push prealbumin above 20 mg/dL. A low result does not specify a protein dose, and kidney disease, severe illness, fluid restrictions, and refeeding risk can change the appropriate plan.
For adults requiring nutrition support who are not severely ill and are not at refeeding risk, NICE CG32 gives general estimates of 25–35 kcal/kg/day and 0.8–1.5 g protein/kg/day (NICE, 2006). These are planning ranges with clinical exceptions, not instructions for everyone with low prealbumin. The CG32 nutrition-support guidance also addresses fluid, electrolytes, micronutrients, and the route through which nutrition is delivered.
A hypothetical 60 kg adult would have an estimated range of 1,500–2,100 kcal/day and 48–90 g protein/day under those general assumptions. The wide range reflects different needs; it is not a reason to choose the highest protein intake automatically, particularly with kidney disease. Our discussion of viwango vya usalama vya lishe ya figo explains why an AI-generated plan still needs appropriate clinical constraints.
Food fortification or oral nutrition supplements may help when ordinary meals do not meet documented needs, but treating the eating barrier remains necessary. A hypothetical person managing only 50% of meals because of persistent nausea needs evaluation of the nausea as well as a feasible nutrition plan. There is no established prealbumin threshold that automatically requires protein powders, intravenous nutrition, or a particular supplement formulation.
When do low intake and illness need urgent attention?
Urgency comes from symptoms, prolonged inadequate intake, and metabolic risk—not the prealbumin number alone. NICE identifies more than 10 days with little or no nutrition as one high-risk criterion for refeeding problems, which require supervised nutrition restoration.
Seek urgent care for confusion, fainting, severe weakness, inability to keep fluids down, very little urine, or breathing difficulty, regardless of whether prealbumin is 8 or 28 mg/dL. Persistent vomiting or diarrhea can create dehydration and electrolyte problems before a transport-protein result becomes informative. Our digestive warning signs guide helps distinguish symptoms that need assessment rather than another nutrition-marker test.
Refeeding risk depends on history and clinical findings, not on a low prealbumin concentration. NICE lists BMI below 16 kg/m², unintentional weight loss greater than 15% over 3–6 months, more than 10 days of minimal intake, or low potassium, phosphate, or magnesium before feeding as individual high-risk criteria; combinations of less severe findings can also qualify. A normal initial electrolyte result does not guarantee that body stores are adequate.
For people who have eaten little or nothing for more than 5 days, NICE recommends initially introducing nutrition at no more than 50% of requirements for the first 2 days, with monitoring. High-risk plans may start at no more than 10 kcal/kg/day under experienced clinical supervision, with thiamine and electrolyte management (NICE, 2006). These figures explain why simply drinking several high-calorie supplements at once can be unsafe after prolonged restriction—they are not a home treatment protocol.
How can AI help interpret prealbumin safely?
AI can explain prealbumin terminology, organize related results, and identify missing context; it cannot diagnose nutritional status from a laboratory report alone. A result of 12 mg/dL needs information about illness, intake, weight, medications, and organ function before its meaning becomes clearer.
Kantesti is an AI blood test interpretation platform that helps explain why prealbumin of 12 mg/dL and CRP of 90 mg/L should be read as different measurements. Our maelezo ya teknolojia ya AI describes the interpretation workflow; the safe clinical boundary remains the same whether the explanation is generated quickly or reviewed slowly. Software cannot palpate muscle, observe swallowing, or independently verify the meals someone actually consumed.
A useful interpretation separates measured facts from missing information instead of presenting one confident diagnosis. For example, a hypothetical report containing prealbumin 12 mg/dL but no CRP or weight history should describe those gaps and suggest discussion of nutritional screening, rather than assign a malnutrition grade. Check whether the explanation preserves your laboratory's units and reference interval before using it to prepare questions for an appointment.
Clinical standards should be judged against the specific task, not a broad accuracy claim that covers every medical decision. Even a correct interpretation of 20 mg/dL cannot establish nutrition adequacy without an assessment, and no software benchmark changes that limitation. Our mfumo wa uthibitishaji na usimamizi is relevant to evaluating methodology; decisions about nutrition support, diagnosis, or urgent care remain matters for qualified healthcare professionals.
Which publications support these nutrition limits?
The clinical conclusions here rest on nutrition guidance, not on unrelated AI publications. The 2021 ASPEN position paper, the 2019 GLIM consensus, and NICE CG32 address different questions: protein-marker limitations, malnutrition diagnosis, and safe nutrition support.
ASPEN's 2021 paper explains why low visceral proteins should not serve as nutrition markers, while GLIM's 2019 consensus specifies the clinical criteria needed to diagnose malnutrition. Neither establishes a prealbumin-only diagnostic cutoff such as 10 or 15 mg/dL; these numbers can describe laboratory abnormalities without proving their cause. NICE CG32 adds practical safety guidance for nutrition support, including the separate assessment of refeeding risk.
Shared inflammatory effects also explain why a broader laboratory panel needs careful interpretation rather than simple abnormal-result counting. A hypothetical low prealbumin of 13 mg/dL alongside low transferrin may reflect one acute-phase mechanism; ferritin can move in the opposite direction during inflammation and complicate assessment of iron stores. Our mwongozo wa kutafsiri vipimo vya chuma explains why biochemical pattern recognition must remain connected to the clinical question.
Kantesti's 2 Figshare publications listed below concern women's health education and multilingual hantavirus decision support, respectively. They are included as separate research resources, not as evidence that prealbumin diagnoses malnutrition or that an AI nutrition plan improves clinical outcomes. Our viwango vya maudhui ya matibabu explain the source-quality distinction readers should expect: a repository DOI identifies a publication, but it does not by itself establish peer review or relevance to this nutrition question.
Maswali ya mara kwa mara
Je, kiwango cha chini cha prealbumini humaanisha utapiamlo kila wakati?
Kiwango cha chini cha prealbumin hakimaanishi kila mara utapiamlo na hakiwezi kuutambua chenyewe. Matokeo ya 12 mg/dL yanaweza kuashiria uvimbe, kupungua kwa uzalishaji wa ini, ulaji usiotosha, au sababu kadhaa kwa pamoja. Tathmini ya utapiamlo kwa watu wazima huzingatia kupungua kwa uzito bila kukusudia, wingi wa misuli, ulaji au ufyonzaji wa virutubishi, na mzigo wa ugonjwa. Mfumo wa GLIM unahitaji angalau kigezo 1 cha kifeno na kigezo 1 cha kiini cha sababu baada ya uchunguzi wa hatari ya lishe.
Kiwango cha kawaida cha prealbumini ni kipi?
Kipindi cha marejeo cha prealbumin kinachotumiwa kwa kawaida kwa watu wazima ni takriban 20–40 mg/dL, sawa na 0.20–0.40 g/L. Baadhi ya maabara hutumia vipindi tofauti, kwa hiyo kipimo kilichochapishwa kwenye ripoti yako ndicho kinachopaswa kuzingatiwa. Thamani ya 200 mg/L ni sawa na 20 mg/dL, jambo muhimu unapolinganisha ripoti zenye vipimo tofauti. Matokeo yaliyo ndani ya kipindi hicho hayaondoi uwezekano wa utapiamlo, na matokeo ya watoto yanahitaji tafsiri inayozingatia umri.
Je, uvimbe unaweza kupunguza kiwango cha prealbumin ingawa ninakula vya kutosha?
Uvimbe unaweza kupunguza kiwango cha prealbumin hata kama ulaji wa chakula wa hivi karibuni unatosha, kwa sababu prealbumin ni protini ya awamu kali hasi. Nusu ya maisha yake ya takriban siku 2–3 huruhusu viwango kubadilika haraka kiasi kadiri uzalishaji wa protini kwenye ini unavyobadilika wakati wa ugonjwa. CRP inaweza kusaidia kutambua hali hii, lakini hakuna fomula iliyothibitishwa ya kurekebisha CRP ili kutathmini hali ya lishe. Kula vya kutosha pia hakuzuii kabisa upotevu wa misuli unaohusiana na ugonjwa wakati wa hali ya muda mrefu ya uvunjaji wa tishu.
Je, kiwango cha prealbumini kilicho chini ya 10 mg/dL ni hatari?
Prealbumini iliyo chini ya 10 mg/dL iko chini sana ya viwango vingi vya marejeo kwa watu wazima, lakini si kizingiti cha dharura kinachojitegemea wala daraja lililothibitishwa la ukali wa utapiamlo. Wahudumu wa afya hutathmini ugonjwa wa msingi, ulaji wa chakula, mabadiliko ya uzito, utendaji wa viungo na dalili ili kubaini kiwango cha uharaka. Kuchanganyikiwa, kuzimia, kushindwa kubakiza maji tumboni, kutoa mkojo kidogo sana au kupata shida ya kupumua kunahitaji tathmini ya haraka bila kujali matokeo ya prealbumini. Ulaji mdogo sana wa chakula kwa muda mrefu pia unahitaji kutathminiwa kuhusu hatari ya ugonjwa wa kurejesha lishe kabla ya kuongeza lishe kwa kasi.
Prealbumini inapaswa kuimarika kwa kasi gani lishe inapoboreka?
Hakuna ratiba ya kuaminika ya kuongezeka kwa prealbumin inayothibitisha kuwa matibabu ya lishe yanafanya kazi. Ingawa nusu ya maisha yake ni takriban siku 2–3, kiwango cha prealbumin kinaweza kuongezeka kutokana na kupungua kwa uvimbe au mabadiliko ya athari za dawa na maji mwilini. Kwa hiyo, ongezeko la kudhaniwa kutoka 10 hadi 18 mg/dL haliwezi, lenyewe, kupima kupona kwa hali ya lishe. Ufuatiliaji unapaswa kuzingatia zaidi kiasi cha chakula kilichorekodiwa, uzito unaotathminiwa pamoja na uwiano wa maji mwilini, utendaji wa misuli na hali ya msingi ya kiafya.
Je, ninapaswa kutumia virutubisho vya protini kwa sababu ya kiwango cha chini cha prealbumini?
Matokeo ya chini ya prealbumin pekee hayathibitishi kwamba virutubisho vya protini vinahitajika wala hayaainishi dozi salama. Kwa baadhi ya watu wazima wanaohitaji usaidizi wa lishe bila ugonjwa mkali au hatari ya refeeding, NICE hutoa makadirio ya jumla ya kupanga ya gramu 0.8–1.5 za protini/kg/siku, lakini mahitaji na vizuizi vya mtu binafsi hutofautiana. Ugonjwa wa figo, matatizo ya kumeza na ulaji mdogo sana kwa muda mrefu vinaweza kubadilisha mpango unaofaa. Jadili kiasi halisi cha chakula unachokula na hatari za lishe na mtaalamu wa afya au mtaalamu wa lishe badala ya kujaribu kuongeza kiwango cha maabara.
Pata maelezo ya jinsi ya kusoma matokeo ya vipimo vya damu
Pakia ripoti yako ya maabara na AI ya Kantesti itaeleza kila kiashiria cha kibayolojia kwa lugha rahisi ndani ya sekunde chache. Inatumiwa na zaidi ya watu milioni 2 duniani kote.
Marejeleo
- Klein, T., Mitchell, S., & Weber, H. (2026). Mwongozo wa Afya ya Wanawake: Ovulesheni, Kukoma Hedhi na Dalili za Homoni. Utafiti wa Kimatibabu wa AI ya Kantesti. DOI
- Klein, T., Mitchell, S., & Weber, H. (2026). Usaidizi wa Maamuzi ya Kliniki Unaosaidiwa na AI kwa Lugha Nyingi kwa Uchunguzi wa Awali wa Hantavirus: Muundo, Uthibitishaji wa Uhandisi na Utekelezaji wa Ulimwengu Halisi katika Ripoti 50,000 za Vipimo vya Damu Zilizotafsiriwa. Utafiti wa Kimatibabu wa AI ya Kantesti. DOI
- Evans DC et al. (2021). The Use of Visceral Proteins as Nutrition Markers: An ASPEN Position Paper. Nutrition in Clinical Practice. DOI
- Cederholm T et al. (2019). GLIM criteria for the diagnosis of malnutrition – A consensus report from the global clinical nutrition community. Clinical Nutrition. DOI
- National Institute for Health and Care Excellence (2006). Nutrition support for adults: oral nutrition support, enteral tube feeding and parenteral nutrition. NICE Clinical Guideline CG32.
- 2M+Vipimo vilivyochanganuliwa
- 127+Nchi
- 100+Lugha
Kuhusu timu ya matibabu
E-E-A-T Trust Signals
Uzoefu
Mapitio ya kimatibabu inayoongozwa na daktari ya mifumo ya tafsiri ya maabara.
Utaalamu
Kuzingatia dawa za maabara kuhusu jinsi viashiria (biomarkers) vinavyobadilika katika muktadha wa kliniki.
Mamlaka
Imekaguliwa kimatibabu na Dkt. Thomas Klein, kwa michango kutoka kwa Dkt. Sarah Mitchell na Prof. Dkt. Hans Weber.
Uaminifu
Tafsiri inayotegemea ushahidi yenye njia zilizo wazi za ufuatiliaji ili kupunguza tahadhari za hofu.
Kanusho la kimatibabu
Makala haya ni kwa madhumuni ya elimu tu na si ushauri wa kimatibabu. Wasiliana na mtoa huduma aliyehitimu kila wakati kwa maamuzi ya utambuzi na matibabu.
Imechapishwa · Wasiliana na timu ya uhariri
Imechapishwa na Kantesti Ltd, imesajiliwa nchini Uingereza na Wales, nambari ya kampuni. 17090423, London, Uingereza.
